Conville P S, Andrews J W, Witebsky F G
Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892-1508, USA.
J Clin Microbiol. 1995 Aug;33(8):2012-5. doi: 10.1128/jcm.33.8.2012-2015.1995.
Mycobacterium kansasii isolates from two patients showed relatively slow growth in BACTEC 12B medium (12B) (Becton Dickinson Diagnostic Instrument Systems, Sparks, Md.) compared with the more rapid growth of these isolates on solid media. This finding prompted an evaluation of the effect of PANTA (Becton Dickinson) on the growth rate of these isolates. Suspensions of one isolate from each of these two patients (A and B), six additional isolates from six other patients (C through H), and one M. kansasii American Type Culture Collection isolate were inoculated into 12B with PANTA, 12B with reconstituting fluid only, and Middlebrook 7H11 agar plates (Remel, Lenexa, Kans.). For the isolates from patients A and B, the average times to detection for 12B with PANTA, 12B with reconstituting fluid, and Middlebrook 7H11 agar were 12.3, 7.4, and 9.0 days, respectively. For the remaining six patient isolates and the American Type Culture Collection strain, the average times to detection for these media were 9.2, 8.1, and 9.6 days. Susceptibility tests performed with the isolates from patients A and B with the individual component antibiotics of PANTA and testing of four of the other isolates with nalidixic acid alone suggested that nalidixic acid exerts some degree of inhibition on the growth of M. kansasii. The eight patient isolates were also inoculated onto Lowenstein Jensen medium (Remel) and onto a variety of selective mycobacterial media containing nalidixic acid and other antimicrobial agents. All isolates showed some degree of inhibition on at least one of these selective media.
与堪萨斯分枝杆菌在固体培养基上生长较快相比,从两名患者分离出的堪萨斯分枝杆菌菌株在BACTEC 12B培养基(12B)(Becton Dickinson诊断仪器系统公司,马里兰州斯帕克斯)中生长相对缓慢。这一发现促使对PANTA(Becton Dickinson公司)对这些菌株生长速率的影响进行评估。将来自这两名患者(A和B)各一名的菌株、来自其他六名患者(C至H)的另外六株菌株以及一株堪萨斯分枝杆菌美国模式培养物保藏中心菌株的悬液接种到含PANTA的12B培养基、仅含复溶液的12B培养基和Middlebrook 7H11琼脂平板(Remel公司,堪萨斯州莱尼克斯)中。对于来自患者A和B的菌株,含PANTA的12B培养基、含复溶液的12B培养基和Middlebrook 7H11琼脂平板的平均检测时间分别为12.3天、7.4天和9.0天。对于其余六名患者的菌株和美国模式培养物保藏中心菌株,这些培养基的平均检测时间分别为9.2天、8.1天和9.6天。对来自患者A和B的菌株用PANTA的各个成分抗生素进行的药敏试验以及对其他四株菌株单独用萘啶酸进行的检测表明,萘啶酸对堪萨斯分枝杆菌的生长有一定程度的抑制作用。这八株患者菌株还接种到罗-琴培养基(Remel公司)以及多种含萘啶酸和其他抗菌剂的选择性分枝杆菌培养基上。所有菌株在至少一种这些选择性培养基上均表现出一定程度的抑制作用。